Results 1 to 2 of 2

Thread: Growing evidence supporting the use of mesenchymal stem cell therapies in MS

  1. #1

    Growing evidence supporting the use of mesenchymal stem cell therapies in MS

    Mult Scler Relat Disord. 2019 Nov 18

    Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: A systematic review.

    Oliveira AG1, Gon?alves M1, Ferreira H2, M Neves N3.
    Author information
    1
    Medicine School, University of Minho, Campus de Gualtar, Braga 4710-057, Portugal.
    2
    3B's Research Group, I3B's - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark, Parque de Ci?ncia e Tecnologia, Zona Industrial da Gandra, Barco, Guimar?es 4805-017, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga, Guimar?es, Portugal. Electronic address: helenaferreira@i3bs.uminho.pt.
    3
    3B's Research Group, I3B's - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark, Parque de Ci?ncia e Tecnologia, Zona Industrial da Gandra, Barco, Guimar?es 4805-017, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga, Guimar?es, Portugal; The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, Barco, Guimar?es 4805-017, Portugal. Electronic address: nuno@i3bs.uminho.pt.
    Abstract
    BACKGROUND:
    Multiple sclerosis (MS) typically arises in early/middle adulthood and is characterized by a progressive disability of the central nervous system (CNS). Currently approved therapies do not promote tissue repair or stop disease progression. Emerging data demonstrate that stem cells present a great potential in regenerative medicine and, consequently, have also been widely investigated as a potential treatment for MS. Therefore, the aim of this study was to conduct a systematic review to inquire into the safety, tolerability, and efficacy of mesenchymal stem cells (MSCs) therapies in MS.

    METHODS:
    Three electronic databases (Web of Science, PubMed, and Cochrane) were searched from April until June 2019. Clinical trials or case reports with information related to the effects of MSC therapies in MS patients were considered for this review.

    RESULTS:
    10 manuscripts were selected, namely 7 uncontrolled clinical trials, 2 randomized controlled clinical trials, and 1 case report. The overall quality of the studies was considered good. Besides minor adverse events (AEs), it was reported one case of encephalopathy with seizures and two cases of iatrogenic meningitis, which were not related to the treatment, but with the administration route. The analyses of the expanded disability status scale (EDSS) in the uncontrolled clinical trials demonstrated that 48 patients improved, 39 maintained and 16 worsened their clinical condition. Regarding the randomized studies, one did not show statistically significant variations in the mean EDSS score and in the other the mean EDSS score was statistically significantly lower for the experimental group. The case report also showed an improvement in the EDSS score.

    CONCLUSIONS:
    MSCs transplantation proved to be a safe and tolerable therapy. Their potential therapeutic benefits were also validated. However, larger placebo controlled blinded clinical trials will be required to establish the long term safety and efficacy profile of these therapies for MS. Their translation into the clinical practice can provide a new hope for the patients of this highly debilitating disease.

    Copyright ? 2019. Published by Elsevier B.V.

    KEYWORDS:
    Adverse events; Expanded disability status scale; Mesenchymal stem cells; Multiple sclerosis; Therapeutic efficacy

    https://www.ncbi.nlm.nih.gov/pubmed/31765999
    “As the cast of villains in SCI is vast and collaborative, so too must be the chorus of hero's that rise to meet them” Ramer et al 2005

  2. #2
    Wildwilly, my good friend just told me Her lumbar puncture proved to be positive for multiple sclerosis. She is already changing her diet to low on saturated fats and is now a pure vegan. I am not certain this is the best route to go but she doesn't want to go on any medication until she tries this for six months. I take it you have a lot of experience with multiple sclerosis? If so do you have suggestions where I can steer her and make sure she's not making any long-term mistakes?

Similar Threads

  1. Replies: 0
    Last Post: 07-07-2006, 08:42 PM
  2. Senator Corzine gives a public speech supporting stem cell research in New Jersey
    By Wise Young in forum Funding, Legislation, & Advocacy
    Replies: 0
    Last Post: 07-06-2005, 03:29 PM
  3. Replies: 0
    Last Post: 08-18-2004, 10:24 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •